Benitec Biopharma (BNTC) EBITDA Margin (2019 - 2025)
Benitec Biopharma's EBITDA Margin came in at -64700.00% for fiscal Q4 2023 (quarter ended Jun 30, 2023), down 56720.37 percentage points from the prior quarter.
Powered by 
Analysis
Benitec Biopharma (BNTC) EBITDA Margin (2019 - 2025) Analysis & Trends
For FY2023 (ended Jun 30, 2023), Benitec Biopharma's EBITDA Margin was -25260.00%, down 1031.23 percentage points from FY2022.
- EBITDA Margin has declined in each of the last four fiscal years, with a four-year change of -25282.47 percentage points (FY2019 to FY2023).
- Going back by fiscal year, EBITDA Margin was -24228.77% in FY2022 (-1576.22 pp), -22652.54% in FY2021 (-14720.19 pp), -7932.35% in FY2020 (-7954.82 pp) and 22.47% in FY2019.
- The fiscal Q4 2023 figure represents the lowest quarterly EBITDA Margin since fiscal Q4 2021.
- Year-over-year, EBITDA Margin increased in two of the last four quarters, with an average year-over-year change of +161010.45 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Benitec Biopharma | 392.02 Mn | -169.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -934.56% |
| Jun 30, 2023 | -63,800.00% |
| Mar 31, 2023 | -7,866.67% |
| Dec 31, 2022 | -39,342.86% |
| Mar 31, 2022 | -6,970.83% |
| Dec 31, 2021 | -18,888.00% |
| Jun 30, 2021 | -187,650.00% |
| Mar 31, 2021 | -367,800.00% |
| Dec 31, 2020 | -314,400.00% |
| Sep 30, 2020 | -4,723.64% |
| Mar 31, 2020 | -7,200.00% |
| Dec 31, 2019 | -2,616.88% |
| Sep 30, 2019 | -3,239.39% |
API Access
Benitec Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();